PubMed=15790775; DOI=10.1634/stemcells.2004-0201
Inzunza J., Gertow K., Stromberg A.-M., Matilainen E., Blennow E., Skottman H., Wolbank S., Ahrlund-Richter L., Hovatta O.
Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells.
Stem Cells 23:544-549(2005)

PubMed=20198446; DOI=10.1007/s11626-010-9308-0; PMCID=PMC2855803
Strom S., Holm F., Bergstrom R., Stromberg A.-M., Hovatta O.
Derivation of 30 human embryonic stem cell lines -- improving the quality.
In Vitro Cell. Dev. Biol. Anim. 46:337-344(2010)

PubMed=21217828; DOI=10.1371/journal.pone.0015329; PMCID=PMC3013107
Strom S., Rodriguez-Wallberg K., Holm F., Bergstrom R., Eklund L., Stromberg A.-M., Hovatta O.
No relationship between embryo morphology and successful derivation of human embryonic stem cell lines.
PLoS ONE 5:E15329-E15329(2010)

PubMed=28445466; DOI=10.1038/nature22312; PMCID=PMC5427175
Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C., Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G., Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A., Eggan K.C.
Human pluripotent stem cells recurrently acquire and expand dominant negative p53 mutations.
Nature 545:229-233(2017)

PubMed=32339905; DOI=10.1016/j.scr.2020.101810
Main H., Hedenskog M., Acharya G., Hovatta O., Lanner F.
Karolinska Institutet Human Embryonic Stem Cell Bank.
Stem Cell Res. 45:101810-101810(2020)